By Associate Professor Marianne Kate Martinello

Book Chapters

Hajarizadeh B; Martinello M; Dore G, 2021, 'HCV Elimination in Australia', in Hepatitis C: Epidemiology, Prevention and Elimination Volume 1, Springer, https://doi.org/10.1007/978-3-030-64649-3_11

Dore GJ; Martinello M, 2020, 'Global elimination of hepatitis C virus by 2030: The optimistic view', in Clinical Dilemmas in Viral Liver Disease Second Edition, pp. 238 - 243, http://dx.doi.org/10.1002/9781119533481.ch40

Grebely J; Martinello M, 2020, 'Harm reduction strategies to prevent new infections and reinfections among people who inject drugs: How effective are they?', in Clinical Dilemmas in Viral Liver Disease Second Edition, pp. 106 - 111, http://dx.doi.org/10.1002/9781119533481.ch18

Martinello M; Hajarizadeh B; Grebely J; Matthews G; Dore G, 2019, 'Cure and Control: What Will It Take to Eliminate HCV?', in Sofia M (ed.), HCV: The Journey from Discovery to a Cure: Volume II, Springer International Publishing, pp. 447 - 490, http://dx.doi.org/10.1007/7355_2018_56

Mills J; Crowe SM; Martinello MK, 2017, 'Investigational antiviral drugs', in Kucers' The Use of Antibiotics A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set, CRC Press

Martinello MK; Grebely J; Dore G, 2017, 'Protease, polymerase and assembly inhibitors for the treatment of hepatitis C virus infection', in Kucers' The Use of Antibiotics A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set, CRC Press

Matthews G; Martinello MK; van Beek I; Burns M, 2014, 'Exposure and acute viral hepatitis', in HIV, Viral Hepatitis and STIs: A Guide for Primary Care

Journal articles

Nyein PP; Haskelberg H; Martinello M; Lowe M; Goodman-Meza D; Avihingsanon A; Kelleher AD; Rodgers A; Schutte AE; Nnakelu EC; Byakwaga H; Trevillyan J; Losso M; Kumarasamy N; Azwa RISR; Kaplan R; Clifton B; Arnott C; Dharan NJ; Petoumenos K; Matthews GV, 2026, 'Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk', Trials, 27, http://dx.doi.org/10.1186/s13063-026-09723-2

Carson JM; Barbieri S; Verich A; Tu E; Lloyd A; Dore GJ; Matthews GV; Martinello M, 2026, 'Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response', Journal of Viral Hepatitis, 33, pp. e70229, http://dx.doi.org/10.1111/jvh.70229

Page K; Goyal A; Cotler SJ; Mathews G; Kushner T; Etzion O; Martinello M; Dahari H, 2026, 'Reply to Akiyama and Berk: Response-Guided HCV Therapy and the Imperative to Treat in Carceral Settings', Journal of Infectious Diseases, pp. jiag374, http://dx.doi.org/10.1093/infdis/jiag374

Degenhardt L; Farrell M; Doyle M; Stone J; Bharat C; Hickman M; Martinello M; Weatherburn D; Dean K; Coyte J; Macdonald C; Harrod ME; Grant L; Larman G; Vickerman P; McGrath C; Thompson P; Churchill A; Dore G; Santo T, 2026, 'Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70161

Goyal A; Cotler SJ; Matthews GV; Page K; Kushner T; Etzion O; Martinello M; Dahari H, 2026, 'Modeling Predicts Direct-Acting Antiviral Therapy for 5-Weeks May Cure Recent or Chronic Hepatitis C Infection Among People With Undetectable Viral RNA by Day 7', Journal of Infectious Diseases, pp. jiag260, http://dx.doi.org/10.1093/infdis/jiag260

Goodman-Meza D; Martinello M; Masters J; Russell D; Jacka B; Matthews GV; Dore GJ, 2026, 'Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70169

Conway A; Grebely J; Tillakeratne S; Cunningham EB; Munyengeterwa U; Van Dyk J; Martinello M; Carson J; Lafferty L; Bull RA; Horsburgh B; McGrath C; Brown T; Treloar C; Amin J; Degenhardt L; Applegate TL; Dunlop A; Matthews GV; Dore GJ; Lloyd AR; Hajarizadeh B, 2026, 'Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study', International Journal of Drug Policy, 151, http://dx.doi.org/10.1016/j.drugpo.2026.105234

Hajarizadeh B; George J; Levy MT; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate TL; Matthews GV, 2026, 'Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study', Journal of Clinical Microbiology, 64, http://dx.doi.org/10.1128/jcm.01405-25

Wijaya R; Stoddart J; Adhikari A; Abayasingam A; Bartlett AW; Rawlinson W; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Martinello M; Lloyd AR; Tedla N; Bull RA; Walker MR, 2026, 'C3d Complement Activation and Antibody Immunity in Convalescent COVID-19: Insights From Adults and Children', Journal of Immunology Research, 2026, http://dx.doi.org/10.1155/jimr/7429749

Moran C; Martinello M; Dore GJ, 2026, 'Hepatitis C: innovations in therapeutic interventions and elimination strategies', Expert Review of Gastroenterology and Hepatology, 20, pp. 701 - 719, http://dx.doi.org/10.1080/17474124.2026.2716819

Rajkumar A; Martinello M; Hurley S, 2026, 'Mycobacterium chelonae bacteraemia and disseminated infection', Pathology, 58, pp. S78 - S78, http://dx.doi.org/10.1016/j.pathol.2026.01.359

Hosseini-Hooshyar S; Valerio H; Flynn E; Sexton C; Barzi F; Amarasena S; De Koster L; Sellen D; Winterfield N; Grebely J; Matthews GV; Boyd MA; Applegate TL; Petoumenos K; Lafferty L; Dore GJ; Treloar C; Martinello M; Ward J, 2025, 'A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study', BMC Infectious Diseases, 25, http://dx.doi.org/10.1186/s12879-025-12004-z

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, http://dx.doi.org/10.1128/cmr.00162-23

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Legrand NM; Bull RA; Hajarizadeh B; Lloyd AR; Johnston K; Issa K; Harvey C; Arnott A; Dwyer DE; Sintchenko V; Grant L; Dore GJ; Kaldor J; Martinello M, 2025, 'Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia', Emerging Infectious Diseases, 31, pp. 1527 - 1536, http://dx.doi.org/10.3201/eid3108.240571

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

, 2025, 'Erratum', The Medical Journal of Australia, 222, pp. 435 - 435, http://dx.doi.org/10.5694/mja2.52639

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, pp. ofaf257, http://dx.doi.org/10.1093/ofid/ofaf257

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Hengel B; Guy RJ; Casey D; Anderson L; Smith K; Andrewartha K; Applegate TD; Saha A; Cunningham P; DeToca L; Rawlinson WD; Martinello M; Tangey A; Patel P; Shephard MDS; Matthews S; Causer L, 2025, 'Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communities', Medical Journal of Australia, 222, pp. 172 - 178, http://dx.doi.org/10.5694/mja2.52589

Ferson MJ; Flanigan S; Westman ME; Pastrana Velez AM; Knobel B; Cains T; Martinello M, 2025, 'Rare urban-acquired human leptospirosis and environmental health investigation in Sydney, Australia', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.011

Mazigi O; Langley DB; Henry JY; Burnett DL; Sobti M; Walker GJ; Rouet R; Balachandran H; Lenthall H; Jackson J; Ubiparipovic S; Schofield P; Brown SHJ; Schulz SR; Hoffmann M; Pöhlmann S; Post J; Martinello M; Ahlenstiel G; Kelleher A; Rawlinson WD; Turville SG; Bull RA; Stewart AG; Jäck HM; Goodnow CC; Christ D, 2025, 'Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies', Proceedings of the National Academy of Sciences of the United States of America, 122, http://dx.doi.org/10.1073/pnas.2417544121

Tungatt K; Gomes GMC; Fewings NL; Stubis A; Doyle CM; Merheb V; Aggarwal A; Byth K; Robertson H; Dervish S; Maddocks S; Taylor J; Bull RA; Martinello M; Brilot F; Turville SG; Cunningham AL; Sandgren KJ, 2025, 'Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID-19', Clinical and Translational Immunology, 14, http://dx.doi.org/10.1002/cti2.70070

Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Martinello M; Matthews GV, 2024, 'Reinfection after Hepatitis C Virus Treatment - Keep Testing, Keep Treating', JAMA Network Open, 7, pp. e2430290, http://dx.doi.org/10.1001/jamanetworkopen.2024.30290

Elliott S; Flynn E; Mathew S; Hajarizadeh B; Martinello M; Wand H; Ward J, 2024, 'Prevalence of hepatitis C virus exposure and infection among Indigenous and tribal populations: a global systematic review and meta-analysis', Public Health, 233, pp. 65 - 73, http://dx.doi.org/10.1016/j.puhe.2024.04.035

Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394

Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', Jhep Reports, 6, http://dx.doi.org/10.1016/j.jhepr.2024.101022

Lafferty L; Beadman M; Ward J; Flynn E; Hosseini-Hooshyar S; Martinello M; Treloar C, 2024, 'Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia', International Journal of Drug Policy, 125, http://dx.doi.org/10.1016/j.drugpo.2024.104335

Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Ke T; Zhang Y; Pedrana A; Asselin J; Dawe J; Wilkinson A; Schinkel J; Sogni P; Esterle L; Gilbert C; Merchadou L; Gillet S; Khan C; Le Marec F; Perrier A; Shaw I; Martinello M; Applegate T; Carson J; Harney B; Bryant M; Jarrin Vera I; Alejos B; Lazarus JV; Moreno C; Izquierdo R; Rava M; Wang S; Lumia J; Pexos C; Peiris H; Saeed S; Moodie E; Pick N; Conway B; Hull M; Wong A; Gill J; Barrett L; Cohen J; Cox J; Cote P; Haider S; Rouleau D; Vachon ML; Rachlis A; Sandre R; Walmsley S; Sadr A; Cooper C; Sanche S; Salazar-Viscaya L; Kusejko K; Hage K; Requena MB; Girard PM; Brucker M; Vincensini JP, 2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Applegate TL; Causer LM; Gow I; Alternetti N; Anderson L; Borgnolo B; Cooney L; Cunningham P; Fernando M; Hengel B; Huang RL; Kayago K; King JM; Lew HJ; Martinello M; Milic M; Miller K; O’connor S; Patel P; Phillips E; Rawlinson W; Sharma A; Shephard MDS; Tangey A; Smith K; Williams AL; Andrewartha K; Guy R; Matthews SJ, 2024, 'Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care-Real world lessons from remote Australia', Expert Review of Molecular Diagnostics, 24, pp. 1125 - 1138, http://dx.doi.org/10.1080/14737159.2024.2403091

Hajarizadeh B; George J; Levy M; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate T; Matthews G, 2024, 'FRI-403 Evaluation of a novel hepatitis B DNA test from fingerstick capillary blood at the point-of-care as a tool to enhance clinical management', Journal of Hepatology, 80, pp. s776, http://dx.doi.org/10.1016/s0168-8278(24)02164-0

Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker GJ; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck HM; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, 2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5

Gulholm T; Kim MG; Lennard K; Mirdad F; Overton K; Martinello M; Maley MW; Konecny P; Andresen D; Post JJ, 2023, 'Clinical variation in the early assessment and management of suspected community-acquired meningitis: a multicentre retrospective study', Internal Medicine Journal, 53, pp. 2298 - 2306, http://dx.doi.org/10.1111/imj.16076

Pradhan A; Dwyer DE; Hueston L; Asquith W; Dotel R; Nanan R; Wood N; Howard-Jones A; O’Kane GM; Stuart R; Whyler N; Chua K; Gilbey T; Bemand T; Weatherall C; Hammoud M; Martinello M; Joshi N; O’Sullivan M, 2023, '2306. A serosurvey of healthcare workers caring for, or handling specimens from, individuals exposed to, or diagnosed with, SARS-CoV-2 infection (COVID-HEROES)', Open Forum Infectious Diseases, 10, pp. ofad500.1928, http://dx.doi.org/10.1093/ofid/ofad500.1928

Back to profile page